Sign up to save your podcasts
Or
Share The Evolution of Antibody-Drug Conjugate Therapy for Gastric/GEJ Cancers: Latest Data and Clinical Implications
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Evolution of Antibody-Drug Conjugate Therapy for Gastric/GEJ Cancers: Latest Data and Clinical Implications
Could the latest data in novel antibody-drug conjugates reshape your treatment approach for patients with gastric cancer? Credit available for this activity expires: 7/1/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002638?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape Podcasts
4
77 ratings
Could the latest data in novel antibody-drug conjugates reshape your treatment approach for patients with gastric cancer? Credit available for this activity expires: 7/1/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002638?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current
View all
JAMA Editors' Summary
141 Listeners
NEJM This Week
322 Listeners
Emergency Medicine Cases
557 Listeners
JAMA Clinical Reviews
501 Listeners
Behind The Knife: The Surgery Podcast
1,310 Listeners
Neurology® Podcast
300 Listeners
Core EM - Emergency Medicine Podcast
257 Listeners
This Week in Cardiology
881 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
296 Listeners
Frankly Speaking About Family Medicine
261 Listeners
The Curbsiders Internal Medicine Podcast
3,370 Listeners
The ONS Podcast
203 Listeners
JAMA Medical News
92 Listeners
The Clinical Problem Solvers
514 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
27 Listeners
Run the List
249 Listeners